Artios
Merck KGaA signs DNA damage response cancer deal with Artios Pharma
Richard Staines
Artios, cancer, dna damage response, Merck KGaA, R&D
0 Comment
X
Merck KGaA signs DNA damage response cancer deal with Artios Pharma
https://pharmaphorum.com/news/merck-kgaa-signs-dna-damage-response-cancer-deal-with-artios-pharma/
UK’s Artios raises $84m to further DDR drug research
Richard Staines
Artios, Biotech, cancer, Oncology
0 Comment
Management team led development of AZ’s PARP drug Lynparza
X
UK’s Artios raises $84m to further DDR drug research
https://pharmaphorum.com/news/uks-artios-raises-84m-to-further-ddr-drug-research/